That's what produces the dramatic appetite reduction and 1522% body weight loss seen in tirzepatide's clinical trials
Explain when symptoms began, the current medication and dose, the date of the last dose, and whether symptoms followed a dose increase
In mice, ZP-6590 was shown to be able to accentuate the body weight loss caused by semaglutide
Most of the studies included were retrospective observational cohort studies, whereas only 6 were RCTs, all of which were non-GLP-1 AOM studies
If you would like to learn more about GLP-1 medications or want to see if you might be eligible for medication-assisted weight loss, check out Mochi Health, where board-certified obesity medicine physicians can offer expertise in this realm
A few of the most common questions people ask before getting started